IDL-PPBopt: A Strategy for Prediction and Optimization of Human Plasma Protein Binding of Compounds via an Interpretable Deep Learning Method
- 24 May 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 62 (11) , 2788-2799
Abstract
The prediction and optimization of pharmacokinetic properties are essential in lead optimization. Traditional strategies mainly depend on the empirical chemical rules from medicinal chemists. However, with the rising amount of data, it is getting more difficult to manually extract useful medicinal chemistry knowledge. To this end, we introduced IDL-PPBopt, a computational strategy for predicting and optimizing the plasma protein binding (PPB) property based on an interpretable deep learning method. At first, a curated PPB data set was used to construct an interpretable deep learning model, which showed excellent predictive performance with a root mean squared error of 0.112 for the entire test set. Then, we designed a detection protocol based on the model and Wilcoxon test to identify the PPB-related substructures (named privileged substructures, PSubs) for each molecule. In total, 22 general privileged substructures (GPSubs) were identified, which shared some common features such as nitrogen-containing groups, diamines with two carbon units, and azetidine. Furthermore, a series of second-level chemical rules for each GPSub were derived through a statistical test and then summarized into substructure pairs. We demonstrated that these substructure pairs were equally applicable outside the training set and accordingly customized the structural modification schemes for each GPSub, which provided alternatives for the optimization of the PPB property. Therefore, IDL-PPBopt provides a promising scheme for the prediction and optimization of the PPB property and would be helpful for lead optimization of other pharmacokinetic properties.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2019YFA0904800)
- National Natural Science Foundation of China (81872800, 82173746)
- Higher Education Discipline Innovation Project (BP0719034)
This publication has 62 references indexed in Scilit:
- The Use of Pseudo-Equilibrium Constant Affords Improved QSAR Models of Human Plasma Protein BindingPharmaceutical Research, 2013
- ToxAlerts: A Web Server of Structural Alerts for Toxic Chemicals and Compounds with Potential Adverse ReactionsJournal of Chemical Information and Modeling, 2012
- In Silico Toxicology – Non-Testing MethodsFrontiers in Pharmacology, 2011
- The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discoveryNature Reviews Drug Discovery, 2010
- Effect of Protein Binding on the Pharmacological Activity of Highly Bound AntibioticsAntimicrobial Agents and Chemotherapy, 2008
- QSAR Modeling of Human Serum Protein Binding with Several Modeling Techniques Utilizing Structure−Information RepresentationJournal of Medicinal Chemistry, 2006
- Novel potent and selective αvβ3/αvβ5 integrin dual antagonists with reduced binding affinity for human serum albuminEuropean Journal of Medicinal Chemistry, 2006
- Can the pharmaceutical industry reduce attrition rates?Nature Reviews Drug Discovery, 2004
- Protein binding of quinolonecarboxylic acids. I. Cinoxacin, nalidixic acid and pipemidic acid.Chemical and Pharmaceutical Bulletin, 1989
- Effect of Plasma Protein Binding on Renal Clearance of DrugsJournal of Pharmaceutical Sciences, 1980